R&D/Clinical Trials

>

Latest News

Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities
Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities

March 21st 2025

The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, expansions at existing sites, and R&D efforts.

Phase III Trial Shows Novartis’ Gene Therapy Significantly Improves Spinal Muscular Atrophy Outcomes
Phase III Trial Shows Novartis’ Gene Therapy Significantly Improves Spinal Muscular Atrophy Outcomes

March 21st 2025

Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes
Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes

March 19th 2025

Heineman Degois
New Ways of Targeting Cancer: Q&A with Oncolytics Biotech

March 19th 2025

Phase III Trial Data Show Eneboparatide Normalizes Serum Calcium Levels in Chronic Hypoparathyroidism
Phase III Trial Data Show Eneboparatide Normalizes Serum Calcium Levels in Chronic Hypoparathyroidism

March 18th 2025

More News